GB2254326B - Monoclonal antibodies produced by in vitro immunization of lymphocytes - Google Patents

Monoclonal antibodies produced by in vitro immunization of lymphocytes

Info

Publication number
GB2254326B
GB2254326B GB9204928A GB9204928A GB2254326B GB 2254326 B GB2254326 B GB 2254326B GB 9204928 A GB9204928 A GB 9204928A GB 9204928 A GB9204928 A GB 9204928A GB 2254326 B GB2254326 B GB 2254326B
Authority
GB
United Kingdom
Prior art keywords
lymphocytes
monoclonal antibodies
antibodies produced
vitro immunization
immunization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9204928A
Other languages
English (en)
Other versions
GB9204928D0 (en
GB2254326A (en
Inventor
Kazuhiko Kuroda
Hiroki Murakami
Shuichi Hashizume
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga and Co Ltd
Original Assignee
Morinaga and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga and Co Ltd filed Critical Morinaga and Co Ltd
Publication of GB9204928D0 publication Critical patent/GB9204928D0/en
Publication of GB2254326A publication Critical patent/GB2254326A/en
Application granted granted Critical
Publication of GB2254326B publication Critical patent/GB2254326B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/05—Adjuvants
    • C12N2501/054—Muramyle peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB9204928A 1991-03-08 1992-03-06 Monoclonal antibodies produced by in vitro immunization of lymphocytes Expired - Fee Related GB2254326B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP06927391A JP3147916B2 (ja) 1991-03-08 1991-03-08 体外免疫方法

Publications (3)

Publication Number Publication Date
GB9204928D0 GB9204928D0 (en) 1992-04-22
GB2254326A GB2254326A (en) 1992-10-07
GB2254326B true GB2254326B (en) 1995-08-23

Family

ID=13397900

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9204928A Expired - Fee Related GB2254326B (en) 1991-03-08 1992-03-06 Monoclonal antibodies produced by in vitro immunization of lymphocytes

Country Status (5)

Country Link
US (1) US5290681A (enExample)
JP (1) JP3147916B2 (enExample)
DE (1) DE4207365C2 (enExample)
FR (1) FR2673641A1 (enExample)
GB (1) GB2254326B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713250B1 (en) 1997-08-08 2004-03-30 The Research Foundation Of State University Of New York Identification of human allergens and T-lymphocyte antigens in vitro
JP2002112069A (ja) * 2000-07-25 2002-04-12 Matsushita Electric Ind Co Ltd 画像歪補正装置および画像歪補正方法
US7006255B2 (en) * 2001-03-29 2006-02-28 Sharp Laboratories Of America Adaptive image filtering based on a distance transform
EP2121919B1 (en) * 2007-03-22 2012-02-08 Heptares Therapeutics Limited Mutant g-protein coupled receptors and methods for selecting them
GB0724051D0 (en) * 2007-12-08 2008-01-16 Medical Res Council Mutant proteins and methods for producing them
GB0724860D0 (en) 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
GB0802474D0 (en) * 2008-02-11 2008-03-19 Heptares Therapeutics Ltd Mutant proteins and methods for selecting them
US20110112037A1 (en) * 2008-03-05 2011-05-12 Heptares Therapeutics Limited BioPark Crystal structure
GB0910725D0 (en) 2009-06-22 2009-08-05 Heptares Therapeutics Ltd Mutant proteins and methods for producing them
GB201002082D0 (en) 2010-02-09 2010-03-24 Univ Leiden Medical Ct Biological material

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0454225A1 (en) * 1990-04-26 1991-10-30 Akzo Nobel N.V. In-vitro method for amplifying human peripheral blood lymphocytes that produce antigen-specific monoclonal antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862303A (en) * 1972-02-02 1975-01-21 Atomic Energy Commission Method for rapid detection and identification of serological factors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0454225A1 (en) * 1990-04-26 1991-10-30 Akzo Nobel N.V. In-vitro method for amplifying human peripheral blood lymphocytes that produce antigen-specific monoclonal antibodies

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Antibod.Hybridomas,Vol 1,No 1,1990,pages 34-41 Power et al. *
HYBRIDOMA, 10,2,pages 229-239,(1991) *

Also Published As

Publication number Publication date
DE4207365A1 (de) 1992-09-10
GB9204928D0 (en) 1992-04-22
FR2673641B1 (enExample) 1995-02-17
GB2254326A (en) 1992-10-07
FR2673641A1 (fr) 1992-09-11
JP3147916B2 (ja) 2001-03-19
JPH04281799A (ja) 1992-10-07
DE4207365C2 (de) 1999-07-22
US5290681A (en) 1994-03-01

Similar Documents

Publication Publication Date Title
EP0539970A3 (en) Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby
NZ236000A (en) Oligomeric monoclonal igg antibody composition
HU896763D0 (en) Process for the preparation of bispecific monoclonal antibody
FI912016L (fi) In vitro -menetelmä antigeenispesifisten ihmisen monoklonaalisten vasta-aineiden valmistamiseksi
IL93840A0 (en) Novel monoclonal antibody to novel antigen associated with human tumors
GB9112836D0 (en) Production of monoclonal antibodies
EP0312996A3 (en) Anti-human bcdf monoclonal antibody
GB8910395D0 (en) Human monoclonal antibody and hybridoma producing the same
EP0580859A4 (en) Anti-eda monoclonal antibody
GB2254326B (en) Monoclonal antibodies produced by in vitro immunization of lymphocytes
IL90017A0 (en) Monoclonal antibodies
IL100869A0 (en) Monoclonal ige receptor antibodies
ZA898777B (en) Monoclonal antibodies
ZA898499B (en) Anti-fucosylcermiade monoclonal antibody
EP0506523A3 (en) Monoclonal antibodies
EP0460607A3 (en) Novel monoclonal antibody to novel antigen associated with human tumors
EP0285511A3 (en) Monoclonal antibodies and their uses
EP0511300A4 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
ZA89258B (en) Monoclonal antibodies
GB8927389D0 (en) Monoclonal antibodies
GB2207921B (en) Monoclonal antibody to omega-gliadin and hybridoma thereof
GB8820036D0 (en) Monoclonal antibodies
JPS6471483A (en) Monoclonal antibody for immunological detection of phytophthora and hybridoma producing said antibody
ZA912136B (en) Anti-oncostatin m monoclonal antibodies
EP0336441A3 (en) Anti-cpbii monoclonal antibody

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20090306